HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,279,196,000 | +142.9% | 14,264 | +9.9% | 0.20% | +545.2% |
Q1 2017 | $526,599,000 | +91802.1% | 12,980 | -9.0% | 0.03% | -6.1% |
Q4 2016 | $573,000 | +6.1% | 14,258 | -4.4% | 0.03% | +32.0% |
Q3 2016 | $540,000 | +93.5% | 14,910 | +54.7% | 0.02% | +108.3% |
Q2 2016 | $279,000 | – | 9,635 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |